Home / Compliance actions / 489980

FDA Warning Letter — Supreme Rx

Case 489980 — FEI 3012119475

The FDA took a Warning Letter action against Supreme Rx on Feb 18, 2016 (Lakeland, FL). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Supreme Rx
Date
Feb 18, 2016
Fiscal Year
2016
Product Type
Tobacco
Center
CTP
Location
Lakeland, FL (United States)

Facility

Other compliance actions

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.